American Thoracic Society, American Journal of Respiratory and Critical Care Medicine, 7(187), p. 721-727, 2013
DOI: 10.1164/rccm.201211-2004oc
ISEE Conference Abstracts, 1(2013), p. 3135, 2013
DOI: 10.1289/isee.2013.p-2-05-07
Full text: Download
RATIONALE: Ambient air pollution has been suggested as a risk factor for chronic obstructive pulmonary disease (COPD). However, there is a lack of longitudinal studies to support this assertion. OBJECTIVES: To investigate the associations of long-term exposure to elevated traffic-related air pollution and woodsmoke pollution with the risk of COPD hospitalization and mortality. METHODS: This population-based cohort study included a 5-year exposure period and a 4-year follow-up period. All residents aged 45-85 years who resided in Metropolitan Vancouver, Canada, during the exposure period and did not have known COPD at baseline were included in this study (N = 467,994). Residential exposures to traffic-related air pollutants (black carbon, particulate matter < 2.5 µm in aerodynamic diameter, nitrogen dioxide, and nitric oxide) and woodsmoke were estimated using land-use regression models and integrating changes in residences during the exposure period. COPD hospitalizations and deaths during the follow-up period were identified from provincial hospitalization and death registration databases. MEASUREMENTS AND MAIN RESULTS: An interquartile range elevation in black carbon concentrations (0.97×10-5/m, equivalent to 0.78 µg/m3 elemental carbon) was associated with a 6% (95% confidence interval, 2-10%) increase in COPD hospitalizations and a 7% (0-13%) increase in COPD mortality after adjustment for covariates. Exposure to higher levels of woodsmoke pollution (tertile 3 versus tertile 1) was associated with a 15% (2-29%) increase in COPD hospitalizations. There were positive exposure-response trends for these observed associations. CONCLUSIONS: Ambient air pollution, including traffic-related fine particulate pollution and woodsmoke pollution, is associated with an increased risk of COPD.